Top Markets
Coin of the day
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

RGRX
Clasificación en acciones #42502
RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the... RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.
Precio por acción
$0.0007
Última sincronización: 2026-08-11
Capitalización bursátil
$1.05K
Cambio (1 día)
0.00%
Cambio (1 año)
250.00%
País
US
Comercio RegeneRx Biopharmaceuticals, Inc. (RGRX)

Categoría

Historial del precio de la acción de RegeneRx Biopharmaceuticals, Inc. (RGRX)
Precio más alto de cierre: $0.00 el 2026-08-01

Precio más bajo de cierre: $110.06 el 2003-10-01
Historial del precio de la acción de RegeneRx Biopharmaceuticals, Inc. desde 2003 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 -97.59%
2024 1,141.64%
2023 -99.99%
2022 -11.40%
2021 -67.94%
2020 258.85%
2019 26.29%
2018 -40.52%
2017 -42.65%
2016 -16.88%
2015 184.48%
2014 141.27%
2013 -42.28%
2012 -20.49%
2011 -48.51%
2010 -59.48%
2009 -54.58%
2008 16.64%
2007 -51.00%
2006 -27.91%
2005 -24.03%
2004 365.32%
2003 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR